Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores

2024-9-1

Impact of the VTE-PREDICT Calculator on Clinicians’ Decision-Making in Fictional Patients with Venous Thromboembolism A randomized controlled trial

2024-9-1

Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices

2024-9-1

Predictors of Diagnostic Delays and Loss to Follow-up in Women with von Willebrand Disease: A Single-Centre Retrospective Cohort Study

2024-9-1

Fibrinaloid microclots in Long COVID: assessing the actual evidence properly

2024-9-1

Mathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII, IX, or XI deficient blood.

2024-9-1

Hyperfibrinolysis: A Crucial Phenotypic Abnormality of Post-traumatic Fibrinolytic Dysfunction

2024-9-1

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study

2024-9-1

How to undertake procedures while on anti-platelet agents – a haematologist view

2024-8-1

Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency

2024-8-1

Erratum to ‘Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. ’[Res Pract Thromb Haemost. 2024;8:e102437]

2024-8-1

Pharmacokinetics and Pharmacodynamics of Low Doses of Recombinant Tissue Plasminogen Activator to establish a model for biosimilarity comparisons

2024-8-1

Dual Direct Oral Anticoagulant Therapy in Challenging Thrombosis: A Case Series

2024-8-1

Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian University

2024-8-1

Methods of a cluster-randomized, Type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk discharging medical patients to prevent hospital-associated venous thromboembolism

2024-8-1

Intensive Care Treatment in Acute Pulmonary Embolism in Germany, 2016 to 2020: A Nationwide Inpatient Database Study

2024-8-1

G Protein-coupled Receptor Kinase 5 regulates thrombin signaling in platelets

2024-8-1

Cross-reacting anti-porcine FVIII inhibitors in patients with acquired hemophilia A

2024-8-1

Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid

2024-8-1

Prescription and Switching Patterns of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

2024-8-1

Anti-polyphosphate monoclonal antibodies derived from autoimmune mice

2024-8-1

PHYSICIAN PRACTICE PATTERNS ON THE USE OF INFERIOR VENA CAVA FILTERS IN VENOUS THROMBOEMBOLISM

2024-8-1

Plant-derived compounds normalise platelet bioenergetics and function in hyperglycaemia

2024-8-1

LAIR-1 and PECAM-1 function via the same signaling pathway to inhibition GPVI-mediated platelet activation

2024-8-1

A Single-center Study of Patients with Rare Isolated Acquired Clotting Factor Deficiencies Other than Acquired Hemophilia A

2024-8-1

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis and management approaches

2024-8-1

Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by two different plasma-based fibrinolysis assays.

2024-8-1

Proportion and risk factors for hospital-acquired venous thromboembolism in children: A systematic review and meta-analysis of data from 20 million individuals in 22 countries

2024-8-1

Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk

2024-8-1

Can hemophilia be cured? It depends on the definition

2024-8-1

Letter in response to Bounaix et al. “Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature”

2024-7-26

Primary Postpartum Hemorrhage in Women with von Willebrand Disease and Carriers of Hemophilia: A Retrospective Analysis

2024-7-1

Rivaroxaban for Stroke patients with Antiphospholipid Syndrome (RISAPS): protocol for a randomised controlled, phase IIb proof-of-principle trial

2024-7-1

Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies

2024-7-1

Erratum to ‘Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress’ [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]

2024-7-1

Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study

2024-7-1

Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial

2024-7-1

Thromboembolic events in severe postpartum haemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis

2024-7-1

Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function

2024-7-1

A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage

2024-7-1

A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology

2024-7-1

In vitro assessment of the risk of ABCB1-mediated drug–drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines

2024-7-1

Managing Surgical Relapse Risk in Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review

2024-7-1

Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus

2024-7-1

Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia (HIT)

2024-7-1

Spontaneous Bleeding in Chronic Kidney Disease - Global Coagulation Assays May Predict Bleeding Risk

2024-7-1

Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study

2024-7-1

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy

2024-7-1

The Association between Unemployment and Treatment Among Adults with Hemophilia

2024-7-1

Quality of life in the oncological patient with venous thromboembolic disease

2024-7-1